These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 21393859)

  • 1. Hunk is required for HER2/neu-induced mammary tumorigenesis.
    Yeh ES; Yang TW; Jung JJ; Gardner HP; Cardiff RD; Chodosh LA
    J Clin Invest; 2011 Mar; 121(3):866-79. PubMed ID: 21393859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonally up-regulated neu-associated kinase: A novel target for breast cancer progression.
    Zambrano JN; Neely BA; Yeh ES
    Pharmacol Res; 2017 May; 119():188-194. PubMed ID: 28189783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hunk negatively regulates c-myc to promote Akt-mediated cell survival and mammary tumorigenesis induced by loss of Pten.
    Yeh ES; Belka GK; Vernon AE; Chen CC; Jung JJ; Chodosh LA
    Proc Natl Acad Sci U S A; 2013 Apr; 110(15):6103-8. PubMed ID: 23520049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Snf1-related kinase, Hunk, is essential for mammary tumor metastasis.
    Wertheim GB; Yang TW; Pan TC; Ramne A; Liu Z; Gardner HP; Dugan KD; Kristel P; Kreike B; van de Vijver MJ; Cardiff RD; Reynolds C; Chodosh LA
    Proc Natl Acad Sci U S A; 2009 Sep; 106(37):15855-60. PubMed ID: 19717424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of cell survival by HUNK mediates breast cancer resistance to HER2 inhibitors.
    Yeh ES; Abt MA; Hill EG
    Breast Cancer Res Treat; 2015 Jan; 149(1):91-8. PubMed ID: 25515931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HUNK suppresses metastasis of basal type breast cancers by disrupting the interaction between PP2A and cofilin-1.
    Quintela-Fandino M; Arpaia E; Brenner D; Goh T; Yeung FA; Blaser H; Alexandrova R; Lind EF; Tusche MW; Wakeham A; Ohashi PS; Mak TW
    Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2622-7. PubMed ID: 20133759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
    Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFβ signaling.
    Lo PK; Kanojia D; Liu X; Singh UP; Berger FG; Wang Q; Chen H
    Oncogene; 2012 May; 31(21):2614-26. PubMed ID: 21996747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of a potent and selective HUNK inhibitor for treatment of HER2+ breast cancer.
    Dilday T; Abt M; Ramos-Solís N; Dayal N; Larocque E; Oblak AL; Sintim HO; Yeh ES
    Cell Chem Biol; 2024 May; 31(5):989-999.e7. PubMed ID: 38307028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taspase1 cleaves MLL1 to activate cyclin E for HER2/neu breast tumorigenesis.
    Dong Y; Van Tine BA; Oyama T; Wang PI; Cheng EH; Hsieh JJ
    Cell Res; 2014 Nov; 24(11):1354-66. PubMed ID: 25267403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental role of the SNF1-related kinase Hunk in pregnancy-induced changes in the mammary gland.
    Gardner HP; Belka GK; Wertheim GB; Hartman JL; Ha SI; Gimotty PA; Marquis ST; Chodosh LA
    Development; 2000 Oct; 127(20):4493-509. PubMed ID: 11003847
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Ramos-Solis N; Dilday T; Kritikos AE; Yeh ES
    Biomedicines; 2022 Nov; 10(12):. PubMed ID: 36551828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of signal transduction pathways involved in constitutive NF-kappaB activation in breast cancer cells.
    Bhat-Nakshatri P; Sweeney CJ; Nakshatri H
    Oncogene; 2002 Mar; 21(13):2066-78. PubMed ID: 11960379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nuclear receptor coactivator amplified in breast cancer-1 is required for Neu (ErbB2/HER2) activation, signaling, and mammary tumorigenesis in mice.
    Fereshteh MP; Tilli MT; Kim SE; Xu J; O'Malley BW; Wellstein A; Furth PA; Riegel AT
    Cancer Res; 2008 May; 68(10):3697-706. PubMed ID: 18483252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Grb2 and Shc adapter proteins play distinct roles in Neu (ErbB-2)-induced mammary tumorigenesis: implications for human breast cancer.
    Dankort D; Maslikowski B; Warner N; Kanno N; Kim H; Wang Z; Moran MF; Oshima RG; Cardiff RD; Muller WJ
    Mol Cell Biol; 2001 Mar; 21(5):1540-51. PubMed ID: 11238891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN.
    Pianetti S; Arsura M; Romieu-Mourez R; Coffey RJ; Sonenshein GE
    Oncogene; 2001 Mar; 20(11):1287-99. PubMed ID: 11313873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADAMTS18 deficiency associates extracellular matrix dysfunction with a higher risk of HER2-positive mammary tumorigenesis and metastasis.
    Nie J; Dang S; Zhu R; Lu T; Zhang W
    Breast Cancer Res; 2024 Jan; 26(1):19. PubMed ID: 38287441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apigenin induces apoptosis through proteasomal degradation of HER2/neu in HER2/neu-overexpressing breast cancer cells via the phosphatidylinositol 3-kinase/Akt-dependent pathway.
    Way TD; Kao MC; Lin JK
    J Biol Chem; 2004 Feb; 279(6):4479-89. PubMed ID: 14602723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer expressing the activated HER2/neu is sensitive to gefitinib in vitro and in vivo and acquires resistance through a novel point mutation in the HER2/neu.
    Piechocki MP; Yoo GH; Dibbley SK; Lonardo F
    Cancer Res; 2007 Jul; 67(14):6825-43. PubMed ID: 17638894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hunk/Mak-v is a negative regulator of intestinal cell proliferation.
    Reed KR; Korobko IV; Ninkina N; Korobko EV; Hopkins BR; Platt JL; Buchman V; Clarke AR
    BMC Cancer; 2015 Mar; 15():110. PubMed ID: 25881306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.